Ischemin
CAS No. 1357059-00-7
Ischemin ( —— )
Catalog No. M11461 CAS No. 1357059-00-7
A cell permeable CBP bromodomain inhibitor with Kd of 19 uM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameIschemin
-
NoteResearch use only, not for human use.
-
Brief DescriptionA cell permeable CBP bromodomain inhibitor with Kd of 19 uM.
-
DescriptionA cell permeable CBP bromodomain inhibitor with Kd of 19 uM; inhibits the acetyl-lysine binding activity of CBP, inhibits p53 interaction with CBP and decreases p53 transcriptional activity; protects against doxorubicin-induced apoptosis in cardiomyocytes in vitro.
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetBromodomain
-
RecptorBromodomain
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1357059-00-7
-
Formula Weight335.38
-
Molecular FormulaC15H17N3O4S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC1=CC(=C(C=C1N=NC2=C(C=C(C(=C2)C)O)N)S(=O)(=O)O)C
-
Chemical Name5-[(1E)-2-(2-Amino-4-hydroxy-5-methylphenyl)diazenyl]-2,4-dimethylbenzenesulfonic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Borah JC, et al. Chem Biol. 2011 Apr 22;18(4):531-41.
molnova catalog
related products
-
FT-001
FT-001 is a novel potent, orally acitve inhibitor of BET bromodomain with IC50 of 0.1 uM for BRD4 BD1.
-
LP99
LP99 is the first potent and selective BRD7/9 bromodomain inhibitor with Kd of 99 nM for BRD9; inhibits IL‐6 secretion from THP‐1 cells in a dose‐dependent manner.
-
GNE-375
GNE-375 is a potent, selective BRD9 inhibitor with IC50 of 5 nM.